Published by
@ShahidNShah
@ShahidNShah
0-50Healthcare
245 Main Street, Cambridge, Massachusetts, 02142, United States
nQ Medical, Inc. is pioneering digital biomarker development to accelerate research, advance disease detection, and improve care. nQ’s Digital Neurology is powered by AI analysis of passive personal device interactions. Based on research begun at MIT, our first computationally derived digital biomarker for Parkinson’s disease has received FDA Breakthrough Designation and our de novo application will be submitted at the end of March 2022. FDA clearance is expected within six months; the Software As a Medical Device (SaMD) was submitted in the market March 2022.
nQ Cortex is a data sciences platform that has been designed to offer a range of powerful insights through AI-powered computational biomarkers. The platform is specifically geared towards the …
Posted Biomedical Technology Artificial Intelligence
Last Updated
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Nov 25, 2024 at 2:32am